Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.4425
$0.052513.46%
| Weiss Ratings | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.50 | |||
| Price History | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.75% | |||
| 30-Day Total Return | -26.69% | |||
| 60-Day Total Return | -49.14% | |||
| 90-Day Total Return | -48.61% | |||
| Year to Date Total Return | -48.00% | |||
| 1-Year Total Return | -86.83% | |||
| 2-Year Total Return | -95.75% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -90.61% | |||
| 52-Week Low % Change | 33.69% | |||
| Price | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.71 | |||
| 52-Week Low Price | $0.33 | |||
| 52-Week Low Price (Date) | Mar 17, 2025 | |||
| 52-Week High Price (Date) | May 31, 2024 | |||
| Valuation | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.77M | |||
| Enterprise Value | 2.02M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.79 | |||
| Earnings Per Share Growth | 7.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 2.54 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.44 | |||
| Enterprise Value/EBITDA (TTM) | -0.26 | |||
| Enterprise Value/EBIT | -0.26 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 240 403 4212 | |||
| Address | 401 Professional Drive Gaithersburg, MD 20879 | |||
| Website | www.shuttlepharma.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -113.74% | |||
| Return on Equity | -- | |||
| Income Statement | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -7.69M | |||
| EBIT (TTM) | -7.70M | |||
| Net Income (TTM) | -9.14M | |||
| Net Income Avl. to Common (TTM) | -9.14M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 2.56% | |||
| EPS Diluted (TTM) | -3.79 | |||
| EPS Diluted Growth (Q YOY) | 51.09% | |||
| Balance Sheet | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.92M | |||
| Cash Per Share (Q) | $0.39 | |||
| Total Current Assets (Q) | 2.21M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 709.20K | |||
| Current Ratio (Q) | 1.441 | |||
| Book Value Per Share (Q) | $0.17 | |||
| Total Assets (Q) | 2.51M | |||
| Total Current Liabilities (Q) | 1.53M | |||
| Total Debt (Q) | 1.17M | |||
| Total Liabilities (Q) | 1.80M | |||
| Total Common Equity (Q) | 709.20K | |||
| Cash Flow | SHPH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.92M | |||
| Cash from Financing (TTM) | 3.76M | |||
| Net Change in Cash (TTM) | -656.20K | |||
| Levered Free Cash Flow (TTM) | -4.29M | |||
| Cash from Operations (TTM) | -7.33M | |||
